Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
20,800
-700 (-3.26%)
At close: Jun 5, 2025, 3:30 PM KST
10.46%
Market Cap 144.95B
Revenue (ttm) 69.65B
Net Income (ttm) 15.30B
Shares Out 6.97M
EPS (ttm) n/a
PE Ratio 9.47
Forward PE n/a
Dividend 1,500.00 (7.21%)
Ex-Dividend Date Dec 27, 2024
Volume 20,275
Average Volume 19,186
Open 21,800
Previous Close 21,500
Day's Range 20,650 - 21,950
52-Week Range 14,500 - 22,700
Beta -0.31
RSI 79.45
Earnings Date Aug 14, 2025

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.